doi: 10.1016/j.spen.2020.100829
Reports have shown that, between 2022 and 2023, almost 25,000 people went to the emergency room for side effects caused by the GLP-1 drugs, like Ozempic, that they take to manage their diabetes or off-label for weight loss
LY3437943, a novel triple GIP, GLP-1 and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Expired peptide medications can lose efficacy and may trigger unexpected immune responses
It focuses on metabolic optimization, not short-term weight loss Many individuals seeking sustainable fat loss, improved energy, and better metabolic balance may benefit especially those who struggle despite dieting or experience chronic stress MOTS-C is not a shortcut